Ayahuasca

This article was originally published on Psychedelic Spotlight and appears here with permission. In an unanimous move, Berkeley has officially deprioritized arrests for possession and use of psilocybin and ayahuasca. Berkeley has long been an epicenter of psychedelic research and culture in the...

Dorian Yates, who won the Mr. Olympia title over six consecutive years from 1992 to 1997, was known for training until he nearly dropped and that included hellish workout sessions and steroids.  Though he retired from pro competition in 1997, the British bodybuilder is still in top...

By Lucia Tedesco via El Planteo After Trevor Noah's departure, Chelsea Handler was a guest host on "The Daily Show" this week and, as expected, the laughs were not lacking. “There was a lot of news happening this weekend and I was on ecstasy, so let's get this party started...

(Part three of a three-part series) See previous stories: EXCLUSIVE: Ayahuasca Pill Is Officially Here, Filament CEO Discusses Future Plans EXCLUSIVE: The Psychedelics Debate Is 'Raging' As Filament Debuts Ayahuasca Pill One of the concerns around what is commonly known as natural ...

Part two of a three-part series. Previous story: Standardized Ayahuasca Pill Is Officially Here, Feast Yourself With The Exclusive Details & Insights When it comes to the ayahuasca pill, Filament Health (OTCMTKS: FLHLF) CEO Ben Lightburn says the product won’t just be for the...

Part one of a three-part series. The first medical-grade drug candidate of the psychedelic ayahuasca is being developed. Currently in the form of a pill, the compound was conceived by Vancouver, BC-based natural drug development company Filament Health (OTCMKTS: FLHLF). During the development...

In Australia, a new study conducted by the University of Melbourne analyzed data from an Online Global Ayahuasca Survey conducted between 2017 and 2019 that showed 10,836 people over the age of 18 had used ayahuasca at least once. “With the expansion of ayahuasca ceremonies from their...

Palo Santo Closes $50M Investment Fund Palo Santo, a venture capital fund focused on backing and building emerging psychedelic therapeutics companies, recently announced the closing of its $50 million fund. “Against the backdrop of a growing global mental health crisis, our mission is to...

In view of the numerous activities that took place for Indigenous Peoples’ Day and World Mental Health Day, this might be a good moment to dive into a discussion on the role psychedelics has played in this area for many years and the future...

This article by Emma Stone was originally published on Microdose and appears here with permission. Borrowing from ancient Eastern teachings, Eckhart Tolle once reflected: “The secret of life is to die before you die, and find out there is no death.” This seemingly cryptic maxim conveys...

As more and more public figures share their experience with certain psychedelics such as ayahuasca, people are becoming more open to embracing entheogens, and changes are starting to happen in the regulatory sense as well. On the heels of Green Bay Packers quarterback Aaron Rodgers ...

After recent declarations by Aaron Rodgers on how his experience with ayahuasca and ‘shrooms helped with his career and improved his life on all levels possible, investors Suzie and David Stadnyk came out and shared their own experiment with the hallucinogenic.  They...

Green Bay Packers quarterback Aaron Rodgers opened up about his experience with psychedelics during the Aubrey Marcus Podcast. He said that ayahuasca, a South American (pan-Amazonian) ceremonial hallucinogenic brew from the Amazon basin, helped him “unconditionally...

Here’s a figure that should be seared into the minds of every living American: 22. That’s the shocking number of United States war veterans who commit suicide every single day. Let that number sink in for a minute. In one year’s time, that’s over 8,000 people —...

Psychedelics biotech startup Entheon Biomedical (CSE: ENBI) (OTCQB: ENTBF) announced the approval by the local Dutch ethics committee for a Phase 1 clinical trial evaluating the pharmacokinetics, pharmacodynamics and safety profile of the psychedelic compound DMT. DMT is known as the active...